アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News Release

TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio